Key statistics
As of last trade Valneva SE (AYJ:HAN) traded at 2.61, 3.16% above its 52-week low of 2.53, set on Sep 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.59 |
---|---|
High | 2.61 |
Low | 2.59 |
Bid | 2.60 |
Offer | 2.62 |
Previous close | 2.53 |
Average volume | 342.86 |
---|---|
Shares outstanding | 162.28m |
Free float | 143.02m |
P/E (TTM) | -- |
Market cap | 411.21m EUR |
EPS (TTM) | -0.2443 EUR |
Data delayed at least 15 minutes, as of Sep 23 2024 16:25 BST.
More ▼
Announcements
- Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
- Valneva soumet des demandes d’élargissement de l’indication de son vaccin contre le chikungunya IXCHIQ® à l’EMA et Santé Canada
- Valneva Submits Label Extension Applications for its Chikungunya Vaccine, IXCHIQ®, to EMA and Health Canada
- Valneva Announces the Success of its Private Placement Raising approximately €60 Million
- Valneva annonce le succès de son augmentation de capital et lève environ 60 millions d’euros
- Valneva annonce le lancement d’un projet d’augmentation de capital d’environ 60 millions d’euros
- Valneva Announces the Launch of a Private Placement of Ordinary Shares for Approximately 60 Million Euros
- VALNEVA - Déclaration d’actions et de droits de vote : 31 août 2024
- VALNEVA - Declaration of shares and voting rights: August 31, 2024
- Valneva et Pfizer annoncent de nouvelles données positives de Phase 2 après une vaccination de rappel pour le candidat vaccin contre la maladie de Lyme
More ▼